PHATHOM PHARMACEUTICALS INC. - COMMON STOCK

Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences

12 11 2021 13:30:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, Regulatory, and Business Updates

08 11 2021 05:00:02 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Withdraws Public Offering

27 10 2021 18:47:20 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Proposed Public Offering of 5,000,000 Shares of Common Stock

26 10 2021 13:01:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting

24 10 2021 12:30:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial

18 10 2021 04:00:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)

27 9 2021 05:00:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital

20 9 2021 05:00:01 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Submits Two NDAs to U.S. FDA for Vonoprazan-based Treatment Regimens for the Treatment of H. pylori Infection

08 9 2021 05:00:01 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

31 8 2021 04:45:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Second Quarter 2021 Results and Provides Update Regarding Key Clinical and Regulatory Milestones

10 8 2021 05:00:02 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Mourns the Loss of Chairman and Founder, Tadataka "Tachi" Yamada, M.D.

05 8 2021 04:30:01 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI

02 8 2021 05:30:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

25 5 2021 13:01:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates

11 5 2021 05:00:04 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

06 5 2021 14:48:26 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints

29 4 2021 13:01:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

06 4 2021 05:00:02 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress

30 3 2021 13:05:01 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial

19 1 2021 05:30:00 提供 Nasdaq GlobeNewswire